MedPath

Effect of injection of transamine amine in reducing bleeding

Phase 3
Recruiting
Conditions
kidney stone.
Calculus of kidney and ureter
Registration Number
IRCT20171128037664N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients of PCNL
Adult patient

Exclusion Criteria

Disorders of color recognition
Any allergic reaction to transamine compounds
Taking an anti-coagulant medicine
History of subarachnoid hemorrhage
Liver Dysfunction
Kidney failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: 6,24 and 48 hour after tranexamic acid. Method of measurement: CBC.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath